Updated 4/3/2019. So far nothing in April but the April Fact sheet isn't posted on the Resverlogix website yet.

Based on attendance or presentation at prior events, here is a list of potential events (mostly science meetings, some investor conferences) for Resverlogix in the year of the big news. There is no guarantee that Resverlogix will present at all of the events listed below. Did I miss any? If so, let me know! Archived Q1 events are at the bottom of this message.

Q2 2019:

Vascular Discovery: From Genes to Medicine (Formerly ATVB:PVD): May 14-16, 2019; Boston, MA. Resverlogix IR has indicated that Resverlogix is attending. It is unclear if they are presenting.

European Atherosclerosis Society (EAS) May 26-29, 2019; Maastricht, Netherlands. Norman Wong is on the schedule to present an abstract on Tuesday afternoon May 28th entitled "APABETALONE (RVX-208) ATTENUATES INFLAMMATORY MILIEU UNDERLYING ADHESION OF MONOCYTES TO ENDOTHELIAL CELLS IN TYPE 2 DIABETES MELLITUS WITH CARDIOVASCULAR DISEASE PATIENTS" in the session " New immunomodulatory treatment strategies against atherosclerosis." Abstract currently under embargo and not available.

Gordon Research Conference: Epigenetic Regulation of Cardiovascular Disease: May 26-31, 2019; Hong Kong, China. Dr. Norman Wong is on the schedule in the Epigenetic Therapies for Cardiovascular Disease section.

BIO-International June 3-6, 2019; Philadelphia, PA

American Diabetes Association (ADA) June 7-11, 2019; San Francisco, CA

European Renal Association – European Dialysis and Transplant Association (ERA-EDTA): June 13-16, 2019; Budapest, Hungary

H2 2019:

Alzheimer's Association International Conference (AAIC) July 14-18, 2019; Los Angeles, CA

European Society of Cardiology (ESC) August 31 to Sept 4, 2019; Paris, France

Clinical Trials on Alzheimer's Disease/Asia  (CTAD Asia) September 13-14, 2019; Beijing, China

European Association for the Study of Diabetes (EASD): Sept 16-20, 2019; Barcelona, Spain

American Society for Nephrology (ASN) Kidney Week Nov 5-10, 2019; Washington, D.C.

BIO-Europe Nov 11-13, 2019

American Heart Association (AHA) November 16-18, 2019; Philadelphia, PA

Clinical Trials on Alzheimer's Disease (CTAD) December 4-7, 2019; San Diego, CA

Past Q1 2019:

Biotech Showcase January 7-9, 2019; San Francisco, CA. See here for slide deck.

BIO CEO & Investor Conference February 11-12, 2019; New York, NY. See here for slide deck.

American College Cardiology (ACC) March 16-18, 2019; New Orleans, LA. BETonMACE cognition sub-study poster here; Vascular Inflammation and Cellular Adhesion poster here.

Roth Conference March 17-19, 2019; Orange County, CA. Webcast in advance of conference here and accessible until mid-April. Slide deck for webcast similar to the one below for BIO-Europe.

BIO-Europe Spring March 25-27, 2019; Vienna, Austria. See here for slide deck.

14th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2019): March 26-31, 2019; Lisbon, Portugal. See abstracts here. Endothelial and Microglial Cell Activation poster here. Dr. Cumming's BETonMACE cognition sub-study presentation here.